Reduction of alachlor-induced olfactory mucosal neoplasms by the matrix metalloproteinase inhibitor Ro 28-2653

Toxicologic Pathology

Volumn 33, Issue 5, 2005, Pages 593-599

  Genter, Mary Beth ^a   Warner, Blake M ^a   Krell, Hans Willi ^b   Bolon, Brad ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c GEMpath Inc   (United States)

Author keywords

Alachlor; Herbicide; Matrix metalloproteinase; MMP 2; Neoplasm; Olfactory; Rat

Indexed keywords

ALACHLOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; RO 282653; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HISTOLOGY; IN VIVO STUDY; MALE; NONHUMAN; NOSE CARCINOMA; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; RAT; UPREGULATION; ZYMOGRAPHY;

ACETAMIDES; ANIMALS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NASAL MUCOSA; NOSE NEOPLASMS; PIPERAZINES; PYRIMIDINES; RATS; RATS, LONG-EVANS;

ANIMALIA;

EID: 26944493406     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230500244522     Document Type: Article

References (35)

1. Adachi, Y., Itoh, F., Yamamoto, H., Iku, S., Matsuno, K., Arimura, Y., and Imai, K. (2001). Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer. Tumour Biol 22, 247-53.
2. Ahmed, A. E., Jacob, S., and Nouraldeen, A. M. (1999). Chloroacetonitrile (CAN) induces glutathione depletion and 8-hydroxylation of guanine bases in rat gastric mucosa. J Biochem Mol Toxicol 13, 119-26.
3. Burman, D. M., Shertzer, H. G., Senft, A. P., Dalton, T. P., and Genter, M. B. (2003). Antioxidant perturbations in the olfactory mucosa of alachlor-treated rats. Biochem Pharmacol 66, 1707-15.
4. Coleman, S., Liu, S., Linderman, R., Hodgson, E., and Rose, R. L. (1999). In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms. Chem Biol Interact 122, 27-39.
5. Feig, D. I., Reid, T. M., and Loeb, L. A. (1994). Reactive oxygen species in tumorigenesis. Cancer Res 54 (Supplement 7), 1890-4.
6. Feng, P. C. C., Wilson, A. G. E., McClanahan, R. H., Patanella, J. E., and Wratten, S. J. (1990). Metabolism of alachlor by rat and mouse liver and nasal turbinate tissues. Drug Metab Disp 18, 373-77.
7. Galati, R., Federico, A., Cortese, G., and Zito, R. (1998). Determination of serum levels of 2,6 diethylaniline in laboratory animal treated with Alachlor. Anticancer Res 18, 979-82.
8. Genter, M. B. (2004). Update on olfactory mucosal metabolic enzymes: age-related changes and N-acetyltransferase activities. J Biochem Mol Toxicol 18, 239-44.
9. Genter, M. B., Burman, D., and Bolon, B. (2002a). Progression of alachlor-induced olfactory mucosal tumors in rats. Int J Exp Pathol 83, 303-7.
10. Genter, M. B., Burman, D. M., Dingeldein, M. W., Clough, I., and Bolon, B. (2000). Evolution of alachlor-induced nasal neoplasms in the Long-Evans rat. Toxicol Pathol 28, 770-81.
11. Genter, M. B., Burman, D. M., Vijayakumar, S., Ebert, C. L., and Aronow, B. J. (2002b). Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa. Physiol Genom 12, 35-45.
12. Goss, K. J., Brown, P. D., and Matrisian, L. M. (1998). Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Intl J Cancer 78, 629-35.
13. Grams, F., Brandstetter, H., D'Alo, S., Geppert, D., Krell, H. W., Leinert, H., Livi, V., Menta, E., Oliva, A., and Zimmermann, G. (2001). Pyrimidine-2,4,6-triones: a new effective and selective class of matrix metalloproteinase inhibitors. Biol Chem 382, 1277-85.
14. Guengerich, F. P. (1992). Metabolic activation of carcinogens. Pharmacol Ther 54, 17-61.
15. Guyton, K. Z., and Kensler, T. W. (1993). Oxidative mechanisms in carcinogenesis. Br Med Bull 49, 523-44.
16. Iwai, K., Adachi, S., Takahashi, M., Möller, L., Udagawa, T., Mizuno, S., and Sugawara, I. (2000). Early oxidative DNA damages and late development of lung cancer in diesel exhaust-exposed rats. Environ Res Section A 84, 255-64.
17. Jones, J. L., Glynn, P., and Walker, R. A. (1998). Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189, 161-8.
18. Kallakury, B. V., Karikehalli, S., Haholu, A., Sheehan, C. E., Azumi, N., and Ross, J. S. (2001). Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7, 3113-9.
19. Kimmel, E. C., Casida, J. E., and Ruzo, L. O. (1986). Formamide insecticides and chloroacetanilide herbicides: disubstituted anilines and nitrobenzenes as mammalian metabolites and bacterial mutagens. J Agric Food Chem 34, 157-61.
20. Kupferman, M. E., Fini, M. E., Muller, W. J., Weber, R., Cheng, Y., and Muschel. R. J. (2000). Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 157, 1777-83.
21. Lein, M., Jung, K., Ortel, B., Stephan, C., Rothaug, W., Juchem, R., Johannsen, M., Deger, S., Schnorr, D., Loening, S., and Krell, H. W. (2002). The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene 21, 2089-96.
22. Maquoi, E., Sounni, N. E., Devy, L., Olivier, F., Frankenne, F., Krell, H. W., Grams, F., Foidart, J. M., and Noel, A. (2004). Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clin Cancer Res 10, 4038-47.
23. Moon, R. T., Kohn, A. D., De Ferrari, G. V., and Kaykas, A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5, 691-701.
24. Porter, K. E., Thompson, M. M., Loftus, I. M., McDermott, E., Jones, L., Crowther, M., Bell, P. R., and London, N. J. (1999). Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis. Eur J Vasc Endovasc Surg 17, 404-12.
25. Schock, B. C., Sweet, D. G., Ennis, M., Warner, J. A., Young, I. S., and Halliday. H. L. (2001). Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 50, 29-33.
26. Seomun, Y., Kim, J., Lee, E. H., and Joo, C. K. (2001). Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells. Biochem J 358, 41-8.
27. Siwik, D. A., Pagano, P. J., and Colucci, W. S. (2001). Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280, C53-C60.
28. Tee, L. B., Davies, D. S., Seddon, C. E., and Boobis, A. R. (1987). Species differences in the hepatotoxicity of paracetamol are due to differences in the rate of conversion to its cytotoxic metabolite. Biochem Pharmacol 36, 1041-52.
29. Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., Harrison, D. G., and Tso, P. S. (2001). Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88, 1291-8.
30. United States Environmental Protection Agency (U.S. EPA) (1985). Special review of certain pesticide products. Alachlor: Position Document 1. Office of Pesticide Programs. PB85-175503, NTIS, Springfield, VA.
31. United States Environmental Protection Agency (U.S. EPA) (1998). Reregistration Eligibility Decision (RED). Alachlor. Office of Pesticide Programs. EPA-738-R-98-020, December 1998.
32. Villaret, D. B., Wang, T., Dillon, D., Xu, J., Sivam, D., Cheever, M. A., and Reed, S. G. (2000). Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 110, 374-81.
33. Wetmore, B. A., Mitchell, A. D., Meyer, S. A., and Genter, M. B. (1999). Evidence for site-specific bioactivation of alachlor in the olfactory mucosa of the Long-Evans rat. Toxicol Sci 49, 202-12.
34. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L., and Matrisian, L. M. (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94, 1402-7.
35. Young, J. T. (1981). Histopathologic examination of the rat nasal cavity. Fundam Appl Toxicol 1, 309-12